Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Jul 15, 2017; 9(7): 300-307
Published online Jul 15, 2017. doi: 10.4251/wjgo.v9.i7.300
Published online Jul 15, 2017. doi: 10.4251/wjgo.v9.i7.300
Clinicopathologic characteristics | Univariate analysis, HR (95%CI) | P value | Multivariate analysis, HR (95%CI) | P value |
Sex | 0.798 | |||
Tumor location | 0.685 | |||
The depth of invasion | 0.877 | |||
Perineural invasion | 0.931 | |||
T-stage | 1.404 (1.021-1.930) | 0.037 | ||
Lymph Node | 0.234 (0.080-0.683) | 0.037 | ||
Cancer Stage | 1.173 (1.012-1.359) | 0.034 | ||
CEA | 1.005 (1.00-1.009) | 0.042 | ||
CA19-9 | 1.001 (1.00-1.002) | 0.040 | 1.001 (1.00-1.002) | 0.012 |
NLR | 0.135 | |||
LMR | 0.127 | |||
PLR | 0.064 | |||
PNI | 0.906 (0.865-0.948) | 0.001 | 0.938 (0.891- 0.987) | 0.014 |
- Citation: Akgül Ö, Çetinkaya E, Yalaza M, Özden S, Tez M. Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection. World J Gastrointest Oncol 2017; 9(7): 300-307
- URL: https://www.wjgnet.com/1948-5204/full/v9/i7/300.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i7.300